FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133426611> ?p ?o ?g. }

• W2133426611 endingPage "e115226" @default.
• W2133426611 startingPage "e115226" @default.
• W2133426611 abstract "Objective We investigated plasma and flow cytometric biomarkers of monocyte status that have been associated with prognostic utility in HIV infection and other chronic inflammatory diseases, comparing 81 HIV+ individuals with a range of treatment outcomes to a group of 21 healthy control blood donors. Our aim is to develop and optimise monocyte assays that combine biological relevance, clinical utility, and ease of adoption into routine HIV laboratory practice. Design Cross-sectional evaluation of concurrent plasma and whole blood samples. Methods A flow cytometry protocol was developed comprising single-tube CD45, CD14, CD16, CD64, CD163, CD143 analysis with appropriately matched isotype controls. Plasma levels of soluble CD14 (sCD14), soluble CD163 (sCD163) and CXCL10 were measured by ELISA. Results HIV status was associated with significantly increased expression of CD64, CD143 and CD163 on CD16+ monocytes, irrespective of the virological response to HIV therapy. Plasma levels of sCD14, sCD163 and CXCL10 were also significantly elevated in association with viremic HIV infection. Plasma sCD163 and CXCL10 levels were restored to healthy control levels by effective antiretroviral therapy while sCD14 levels remained elevated despite virological suppression (p<0.001). Conclusions Flow cytometric and plasma biomarkers of monocyte activation indicate an ongoing systemic inflammatory response to HIV infection, characterised by persistent alterations of CD16+ monocyte expression profiles and elevated sCD14 levels, that are not corrected by antiretroviral therapy and likely to be prognostically significant. In contrast, sCD163 and CXCL10 levels declined on antiretroviral therapy, suggesting multiple activation pathways revealed by these biomarkers. Incorporation of these assays into routine clinical care is feasible and warrants further consideration, particularly in light of emerging therapeutic strategies that specifically target innate immune activation in HIV infection." @default.
• W2133426611 created "2016-06-24" @default.
• W2133426611 creator A5015542251 @default.
• W2133426611 creator A5038299372 @default.
• W2133426611 creator A5039351765 @default.
• W2133426611 creator A5042394155 @default.
• W2133426611 creator A5043828683 @default.
• W2133426611 creator A5083599639 @default.
• W2133426611 date "2014-12-29" @default.
• W2133426611 modified "2023-09-30" @default.
• W2133426611 title "Elevated Plasma Soluble CD14 and Skewed CD16+ Monocyte Distribution Persist despite Normalisation of Soluble CD163 and CXCL10 by Effective HIV Therapy: A Changing Paradigm for Routine HIV Laboratory Monitoring?" @default.
• W2133426611 cites W150221401 @default.
• W2133426611 cites W1503584044 @default.
• W2133426611 cites W1964703925 @default.
• W2133426611 cites W1965179482 @default.
• W2133426611 cites W1971514874 @default.
• W2133426611 cites W1975953426 @default.
• W2133426611 cites W1993250333 @default.
• W2133426611 cites W1994201899 @default.
• W2133426611 cites W2006734344 @default.
• W2133426611 cites W2013873031 @default.
• W2133426611 cites W2031360844 @default.
• W2133426611 cites W2043407765 @default.
• W2133426611 cites W2045995185 @default.
• W2133426611 cites W2055303465 @default.
• W2133426611 cites W2061187687 @default.
• W2133426611 cites W2067893593 @default.
• W2133426611 cites W2071398804 @default.
• W2133426611 cites W2083253868 @default.
• W2133426611 cites W2097113013 @default.
• W2133426611 cites W2097433834 @default.
• W2133426611 cites W2097662686 @default.
• W2133426611 cites W2098132798 @default.
• W2133426611 cites W2098152094 @default.
• W2133426611 cites W2102433466 @default.
• W2133426611 cites W2120848334 @default.
• W2133426611 cites W2131614631 @default.
• W2133426611 cites W2137494118 @default.
• W2133426611 cites W2143924656 @default.
• W2133426611 cites W2149105415 @default.
• W2133426611 cites W2151587606 @default.
• W2133426611 cites W2153932008 @default.
• W2133426611 cites W2158550197 @default.
• W2133426611 cites W2170719678 @default.
• W2133426611 cites W2171970710 @default.
• W2133426611 doi "https://doi.org/10.1371/journal.pone.0115226" @default.
• W2133426611 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4278884" @default.
• W2133426611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25544986" @default.
• W2133426611 hasPublicationYear "2014" @default.
• W2133426611 type Work @default.
• W2133426611 sameAs 2133426611 @default.
• W2133426611 citedByCount "28" @default.
• W2133426611 countsByYear W21334266112015 @default.
• W2133426611 countsByYear W21334266112016 @default.
• W2133426611 countsByYear W21334266112017 @default.
• W2133426611 countsByYear W21334266112018 @default.
• W2133426611 countsByYear W21334266112019 @default.
• W2133426611 countsByYear W21334266112020 @default.
• W2133426611 countsByYear W21334266112021 @default.
• W2133426611 countsByYear W21334266112022 @default.
• W2133426611 countsByYear W21334266112023 @default.
• W2133426611 crossrefType "journal-article" @default.
• W2133426611 hasAuthorship W2133426611A5015542251 @default.
• W2133426611 hasAuthorship W2133426611A5038299372 @default.
• W2133426611 hasAuthorship W2133426611A5039351765 @default.
• W2133426611 hasAuthorship W2133426611A5042394155 @default.
• W2133426611 hasAuthorship W2133426611A5043828683 @default.
• W2133426611 hasAuthorship W2133426611A5083599639 @default.
• W2133426611 hasBestOaLocation W21334266111 @default.
• W2133426611 hasConcept C114684123 @default.
• W2133426611 hasConcept C126322002 @default.
• W2133426611 hasConcept C13373296 @default.
• W2133426611 hasConcept C142462285 @default.
• W2133426611 hasConcept C167672396 @default.
• W2133426611 hasConcept C202751555 @default.
• W2133426611 hasConcept C203014093 @default.
• W2133426611 hasConcept C2775858924 @default.
• W2133426611 hasConcept C2776447464 @default.
• W2133426611 hasConcept C2776914184 @default.
• W2133426611 hasConcept C2778513237 @default.
• W2133426611 hasConcept C2779244956 @default.
• W2133426611 hasConcept C2781184567 @default.
• W2133426611 hasConcept C2781197716 @default.
• W2133426611 hasConcept C2781462264 @default.
• W2133426611 hasConcept C3013748606 @default.
• W2133426611 hasConcept C553184892 @default.
• W2133426611 hasConcept C55493867 @default.
• W2133426611 hasConcept C5858377 @default.
• W2133426611 hasConcept C71924100 @default.
• W2133426611 hasConcept C86803240 @default.
• W2133426611 hasConcept C8891405 @default.
• W2133426611 hasConceptScore W2133426611C114684123 @default.
• W2133426611 hasConceptScore W2133426611C126322002 @default.
• W2133426611 hasConceptScore W2133426611C13373296 @default.
• W2133426611 hasConceptScore W2133426611C142462285 @default.
• W2133426611 hasConceptScore W2133426611C167672396 @default.
• W2133426611 hasConceptScore W2133426611C202751555 @default.
• W2133426611 hasConceptScore W2133426611C203014093 @default.

• next